Find the latest pharmaceutical market place for APIs enquiry about Defibrotide Sodium on PharmaCompass.com.

india-flag Flag

Injectable Grade Defibrotide Sodium API needed in India [ENA22621]

A company that focuses on research, development and manufacturing of active ingredients and FDFs is looking for suppliers of Injectable Grade Defibrotide Sodium API. The required quantity is 125 g for development, 375 g for exhibit batches and 125 g for commercial purposes. The suppliers must support this enquiry with GMP & CoA.

Reply

11 Apr 2025

india-flag Flag

Injectable Grade Defibrotide Sodium (MOQ) API needed in India [ENA18080]

A biotechnology company that focuses on the research, development and manufacturing of immunosuppressants, antibiotics, oncology, anti-obesity, hypolipemic segments and enzymes is looking for suppliers of Injectable Grade Defibrotide Sodium (MOQ) API for development purposes. The suppliers must support this enquiry with CoA.

Reply

18 Sep 2023

india-flag Flag

Various APIs needed in India [ENA17258]

A company that deals in various pharmaceutical products is looking for suppliers of Various APIs for commercial purposes. The required quantity is MOQ for each. The suppliers must support this enquiry with CoA.
1. Bemiparin Sodium API
2. Defibrotide Sodium API
3. Ataluren API
4. Vandetanib API
5. Chenodeoxycholic Acid API

Reply

08 Jun 2023

turkeypng-1602828403png-1622460951png-1622462103 Flag

Defibrotide Sodium API needed in Turkey [ENA17150]

A company that focuses on research, development and manufacturing of finished formulations in respiratory, oncology & hematology therapeutic areas is looking for suppliers of Defibrotide Sodium API. The required quantity is 200 g for development and 2 kg for commercial purposes. The suppliers must support this enquiry with GMP & CoA.

Reply

23 May 2023

Various APIs needed in Jordan [ENA12801]

A company that deals in the development, production, and distribution of generic and specialty medicines is looking for suppliers of Various APIs. The suppliers must support this enquiry with CoA.
1. Fondaparinux Sodium API
2. Defibrotide API
3. Bulevirtide API
4. Iron Isomaltoside API
5. Dalteparin Sodium API

Reply

24 Feb 2022

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various APIs needed in Turkey [ENA08324]

An innovative and growth-oriented pharmaceutical Turkish company is looking for suppliers of Various APIs. The suppliers must support this enquiry with DMF or CEP & GMP.
1. Carfilzomib API. The required quantity is 3 g for research purposes & 750 g - 1 kg/ annum for commercial purposes
2. Defibrotide API. The required quantity is 7 kg for research purposes & 25 kg/ annum for commercial purposes
3. Etelcalcetide HCl API. The required quantity is 4 g for research purposes & 100 g/ annum for commercial purposes
4. Nelarabine API. The required quantity is 510 g/annum
5. Ribociclib Succinate API. The quantity is not clear yet.
6. Sodium Benzoate API. The required quantity is 50 kg - 60 kg/ annum
7. Vandetanib API. The required quantity is 10 g - 15 g for research purposes & 7.5 kg/ annum for commercial purposes
8. Vorinostat API. The required quantity is 10 g for research purposes & 12 kg/ annum for commercial purposes

Reply

21 Aug 2020

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various APIs needed in Turkey [ENA06471]

A pharmaceutical manufacturing company that focuses on the fields of oncology, hematology, ophthalmology, and radiology is looking for suppliers of Various APIs for R&D purposes. The suppliers must support this enquiry GMP & USDMF.
1. Nelarabine
2. Defibrotide
3. Eribulin

Reply

04 Feb 2020

Enquiry// Carvedilol Phosphate, Nusinersen and other APIs needed in India [ENA01667]

Esschem Pvt Ltd- a rapidly growing pharmaceutical company based in India is looking for the suppliers of the following:
1) Carvedilol Phosphate
2) Nusinersen
3) Eteplirsen
4) Edaravone
5) Etelcalcetide
6) Abaloparatide
7) Defibrotide
8) Rolapitant
Interested suppliers must contact Subramaniam via E-mail: subu@esschemindia.com or Tel: +919819619256.

Reply

28 Aug 2018